IQVIA Holdings Inc.
IQV · Price history
Price at last available close
$276.89
+$5.92 (+2.18%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About IQVIA Holdings Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes.
How they make money
IQVIA operates as a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company leverages its proprietary health data, Healthcare-grade AI, and domain expertise to help clients improve clinical development and commercialization outcomes.
Products & services
Clinical research services, technology-enabled commercial operations, healthcare data analytics, and software applications for the life sciences and healthcare sectors.
Brands & revenue mix
Core platform integrating data, technology, and analytics.
Separate brand revenue is not available in this research.Source
Proprietary artificial intelligence framework for healthcare data.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Geographic revenue
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Customer types
Customer concentration
No single client accounted for 10% or more of total company revenues in 2025; the largest client contributed approximately 5%.
Suppliers, materials & equipment
No supplier relationships were confirmed in the sources reviewed. This does not mean the company has no suppliers.
Competitors
Strengths
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
34
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
61
Fair
Financial Strength
45
Business Quality / Moat
83
Management
67
Growth Quality
42
Risk / Durability
71
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
24
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
32/100
Building Historical Record
Model Score 32/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Recent buyback activity is present
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for IQV
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can IQV maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is IQV's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is IQV's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •What future growth or profitability would be needed to justify IQV's current valuation?
Essential Investment Snapshot
Wall Street Score
34
Opportunity Score
24
Market Cap
$45.69B
P/E Ratio
33.1
EPS
$8.13
52-Week High
$277.40
52-Week Low
$154.50
Beta
1.19
Intrinsic Value
$137.64
Analyst Target
$258.50
Shares Outstanding
173.5M
Total Revenue
$16.98B
Total Debt
$16.24B
Dividend
No current dividend
Liquidation Value / Share
$36.32
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Building upward momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for IQV
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on IQV.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Extensive proprietary health data assets.
- +Integration of AI and advanced analytics.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Diagnostics & Research industry.
- −Dependence on biopharmaceutical R&D spending levels.
- −Regulatory changes in data privacy and healthcare.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
3 historical score records availablePrevious Score
34
Aug 14, 2026
Change
-0.3
points
Current Score
34
Oct 1, 2026
Category Changes
IQV decreased 0.3 points because Capital declined by 3 points.
Negative Contributors
- − Capital declined by 3 points
Projected Score
Projected Score
35
Projected Change
+0.8 points
Preliminary comparable-period financial changes suggest improvement of approximately 0.8 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$277.58
Model Intrinsic Value
$137.64
Difference
+$139.95
+101.7% vs IV
Margin of Safety
-101.7%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.98B | $16.31B | $15.40B | $14.98B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $12.53B | $12.02B | $10.03B | $9.74B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $4.46B | $4.29B | $5.38B | $5.24B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $2.06B | $2.00B | $1.99B | $2.05B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $2.15B | $2.00B | $3.17B | $3.26B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $3.53B | $3.46B | $3.45B | $3.26B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $2.31B | $2.29B | $2.20B | $1.98B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $771.0M | $729.0M | $670.0M | $672.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | $1.61B | $1.61B | $1.67B | $1.46B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $253.0M | $252.0M | $296.0M | $101.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | $1.38B | $1.36B | $1.37B | $1.36B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $8.13 | $7.91 | $7.57 | $7.39 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 167M | 172M | 181M | 184M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 169M | 174M | 183M | 186M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$4.37B
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$1.53
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
+3.4%
Cash Change
-6.4%
Margin Change
-0.8 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Weakened
- Margins contracted
- Cash position declined
- Debt increased
Potential Score Impact
Positive indicators included revenue growth. Pressure indicators included EPS growth, cash levels, debt levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 8.7%. EPS declined 0.6%. Cash declined 6.4%. Total debt increased 3.4%. Net income margin declined by 0.8 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
7
Smart Money
7
Number of Gurus
1
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
3 historical recordsHistorical Score Chart
3 of 3 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Diagnostics & ResearchNews
IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y
IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates
IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Rumor Mill · IQV
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial